Pain News and Research

Latest Pain News and Research

Japanese bioengineers tweak E. coli genes to pump out morphine precursor

A common gut microbe could soon be offering us pain relief. Japanese bioengineers have tweaked Escherichia coli genes so that they pump out thebaine, a morphine precursor that can be modified to make painkillers. The genetically modified E. coli produces 300 times more thebaine with minimal risk of unregulated use compared to a recently developed method involving yeast.

26 Feb 2016

New review suggests solutions that can help ease chronic pain in women

Women often suffer silently when in pain, whether it's caused by pregnancy discomfort or creaky knees. Yet there are a variety of solutions that can help relieve women of chronic pain, from exercise to identifying triggers, suggests a new review of research related to women and pain by the American Society of Anesthesiologists.

26 Feb 2016

Allergan receives FDA approval to market ACZONE (dapsone) Gel, 7.5% for acne treatment

Allergan plc, a leading global pharmaceutical company, today announced that the Company has received approval from the U.S. Food and Drug Administration to market ACZONE (dapsone) Gel, 7.5%, a new prescription topical treatment for acne in patients 12 years of age and older.

26 Feb 2016

UK is a nation in pain, according to global survey

A global consumer survey has shown that of 14 European countries, the UK is where the most people report feeling body pain, defined as aches in the muscles, joints, tendons, and ligaments.

25 Feb 2016

Insulet partners with Mode AGC to develop OmniPod Artificial Pancreas system

Insulet Corporation, the leader in tubeless insulin pump technology with its OmniPod Insulin Management System (OmniPod System), today announced a license agreement and partnership with Mode AGC (Automated Glucose Control LLC), to develop and incorporate the advanced artificial pancreas algorithm created by renowned researchers Francis Doyle PhD, Eyal Dassau PhD, and Howard Zisser MD.

25 Feb 2016

Study: Magnesium therapy can alleviate muscular symptoms in patients with Motor Neurone Disease

Around 5,000 Motor Neurone Disease (MND) sufferers across the UK could find relief to their muscular symptoms thanks to transdermal (through the skin) magnesium therapy, say health pioneers BetterYou.

From BetterYou Ltd 25 Feb 2016

Vertical Pharmaceuticals launches breakthrough prenatal vitamin supplement: OB Complete Gold

OB Complete Gold is a breakthrough innovation in prenatal vitamin supplements that contains the advanced technology OmEGGa DHA, providing a novel egg-based DHA that comes from cage-free hens.

25 Feb 2016

Study: Most Ebola survivors experience brain symptoms more than six months after initial infection

Most of the 82 Ebola survivors in a new study from the world's largest Ebola outbreak had brain symptoms more than six months after the initial infection. The preliminary results will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, April 15 to 21, 2016.

25 Feb 2016

PolyPid closes $22 million private equity financing

PolyPid Ltd., an emerging clinical-stage specialty pharmaceutical company, focused primarily on the development of post-surgical anti-infection pipeline, announced today that it closed a $22 million private equity financing.

24 Feb 2016

New smart seat cushion may relieve painful pressure ulcers for wheelchair users

Modern-day wheelchairs provide a full range of mobility solutions to those who cannot walk, but many users still battle an unwanted side effect: painful ulcers caused by sitting for long periods in the same position.

24 Feb 2016

New Botox-like treatment can help runners, cyclists with knee pain

A painful knee condition that affects more than one in eight active people has been treated effectively with a botulinum toxin injection and physiotherapy.

24 Feb 2016

UOC initiates U-Motion II+ Acetabular System and UTF Reduced Stem study in patients receiving primary THA

United Orthopedic Corporation, a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments, today announced the start of patient enrollment in a follow-up study in the U.S. of the commercially available U-Motion II+ Acetabular System and UTF Reduced Stem in patients receiving primary total hip arthroplasty.

24 Feb 2016

UMMC surgeons develop a program to direct critically ill patients to appropriate treatment location

A team of surgeons at the University of Maryland Medical Center has developed a program that utilizes its Shock Trauma Center (STC) model to direct critically ill non-trauma patients to the appropriate treatment location and get them into an operating room and hospital intensive care unit (ICU) bed as quickly as possible.

24 Feb 2016

Study: Migraine, tension-type headaches may share genetic links with IBS

Migraine and tension-type headaches may share genetic links with irritable bowel syndrome (IBS), according to a preliminary study released today that will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, April 15 to 21, 2016.

24 Feb 2016

ViiV Healthcare presents positive results from LATTE-2 study at CROI

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive results from the LATTE-2 study at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Headline results were announced in November 2015.

24 Feb 2016

Adapted yoga feasible, beneficial for adults with stroke or traumatic brain injury

A research team, led by an IU School of Health and Rehabilitation faculty member at Indiana University-Purdue University Indianapolis, has determined that adapted yoga is both feasible and beneficial for adults with stroke or traumatic brain injury.

23 Feb 2016

New biological technique may provide better, longer-lasting joint function

According to the Agency for Healthcare Research and Quality, more than 300,000 total hip replacements are performed in the United States each year. The procedure reduces pain and restores mobility. However, for younger, more active patients, an artificial hip has a limited lifetime and usually requires restricted activity.

23 Feb 2016

MDI Biological Laboratory scientist identifies potential drug therapy to reverse peripheral nerve damage

The Mount Desert Island Biological Laboratory has announced that assistant professor Sandra Rieger, Ph.D., has identified two drugs that could potentially be used to reverse peripheral nerve damage, or peripheral neuropathy, resulting from chemotherapy treatment for ovarian, breast, lung, pancreas and other cancers. The drugs also have potential applications for the treatment of peripheral nerve damage caused by diabetes, traumatic injuries and other conditions.

23 Feb 2016

Black, white Americans cope with pain differently

Researchers led by Adam T. Hirsh of the School of Science at Indiana University-Purdue University Indianapolis report that black and white Americans cope with pain differently and that blacks employ pain coping strategies more frequently than whites. The IUPUI review and analysis of 19 studies is the first to examine the entire published literature and quantify the relationship between race and the use of pain-coping strategies.

23 Feb 2016

How to avoid breast damage when exercising: an interview with Professor Joanna Scurr

The breast itself doesn't contain any muscles and the only 2 supporting structures are the skin and the Cooper’s ligaments. Both of those structures are quite weak mechanically so they're not able to hold the breast in place firmly.

23 Feb 2016

Pain News and Research

Latest Pain News and Research

Japanese bioengineers tweak E. coli genes to pump out morphine precursor

New review suggests solutions that can help ease chronic pain in women

Allergan receives FDA approval to market ACZONE (dapsone) Gel, 7.5% for acne treatment

UK is a nation in pain, according to global survey

Insulet partners with Mode AGC to develop OmniPod Artificial Pancreas system

Study: Magnesium therapy can alleviate muscular symptoms in patients with Motor Neurone Disease

Vertical Pharmaceuticals launches breakthrough prenatal vitamin supplement: OB Complete Gold

Study: Most Ebola survivors experience brain symptoms more than six months after initial infection

PolyPid closes $22 million private equity financing

New smart seat cushion may relieve painful pressure ulcers for wheelchair users

New Botox-like treatment can help runners, cyclists with knee pain

UOC initiates U-Motion II+ Acetabular System and UTF Reduced Stem study in patients receiving primary THA

UMMC surgeons develop a program to direct critically ill patients to appropriate treatment location

Study: Migraine, tension-type headaches may share genetic links with IBS

ViiV Healthcare presents positive results from LATTE-2 study at CROI

Adapted yoga feasible, beneficial for adults with stroke or traumatic brain injury

New biological technique may provide better, longer-lasting joint function

MDI Biological Laboratory scientist identifies potential drug therapy to reverse peripheral nerve damage

Black, white Americans cope with pain differently

How to avoid breast damage when exercising: an interview with Professor Joanna Scurr

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Pain News and Research

Latest Pain News and Research

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in